Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Adjuvants to the S1-subunit of the SARS-CoV-2 spike protein vaccine improve antibody and T cell responses and surrogate neutralization in mice

Scientific Reports(2024)10.1038/s41598-024-80636-3Source: DataRank Database

Adjuvants to the S1-subunit of the SARS-CoV-2 spike protein vaccine improve antibody and T cell responses and surrogate neutralization in mice is a research paper published in Scientific Reports (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.88)OA: goldTopics (55)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Khadija Rebbani ORCID,Zhijian Duan ORCID,Eugene Valkov ORCID,Shawn Bryant,Mitchell Ho ORCID

Live enrichment

PubMed:39609527 PMC:PMC11604653 OpenAlex:https://openalex.org/W4404821906

NCI NIH HHS

Grant: ZIA BC010891

NIH HHS

Grant: ZIA BC 011943

NIH HHS

Grant: NIA-C-004020

National Cancer Institute

FWCI

0.88

Citation Percentile

0.7%

Citation Trend

2025

goldLicense: cc-by

journalhttps://www.nature.com/articles/s41598-024-80636-3.pdf

publisherhttps://www.nature.com/articles/s41598-024-80636-3.pdf

publisherhttps://www.nature.com/articles/s41598-024-80636-3

journalhttps://doi.org/10.1038/s41598-024-80636-3

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39609527

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesViral gastroenteritis research and epidemiologyAnimalsSpike Glycoprotein, CoronavirusMiceSARS-CoV-2COVID-19 VaccinesAntibodies, ViralAntibodies, NeutralizingCOVID-19Adjuvants, ImmunologicFemaleHumansT-LymphocytesAdjuvants, VaccineMice, TransgenicImmunoglobulin GMice, Inbred C57BLVaccines, Subunit

MeSH Terms

COVID-19SARS-CoV-2COVID-19 VaccinesAdjuvants, VaccineAdjuvants, ImmunologicAnimalsAntibodies, ViralFemaleHumansImmunoglobulin GMice, Inbred C57BLMice, TransgenicT-LymphocytesVaccines, SubunitMiceAntibodies, NeutralizingSpike Glycoprotein, Coronavirus

Keywords

EctodomainNeutralizationImmunizationAntibodyProtein subunitAdjuvantVirologyImmune systemBiologyImmunologyReceptorGeneBiochemistryAgingVariantsVaccineAdjuvantsSars-cov-2

Sustainable Development Goals

SDG 0: Good health and well-being

Adjuvants to the S1-subunit of the SARS-CoV-2 spike protein vaccine improve antibody and T cell responses and surrogate neutralization in mice

FAIR Checklist

Authors (8)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)